Journal Reviews

American Journal of Rhinology & Allergy cover image.

The future of biologics?

3 July 2023 | | Maxillofacial Surgery, ENTA-Rhinology / Sinus | biological therapy, eosinophil, interleukin-5, nasal polyps, Otorhinolaryngologic diseases

This paper takes a deep dive into how eosinophilia affects the responsiveness of the host to the two monoclonal antibodies mepolizumab and bendralizumab, both of which are active against IL5. We know that eosinophils are attracted and trapped into the...